It's pegged (for now) with the odds strongly in favor of an upside in 3-6 months (at most)... at a "minimum" it will run up prior to the FDA Panel review... of course Scripts and Financials will be watched closely in the mean time which - if they are within what is expected - probably won't have any negative impact.
That means that Amarin has just about hit the bottom. Shorts waiting for another drop won't hang in their much longer (the ones that are still shorting)... that's my opinion. Why would you risk losing what you already have - and to be fair Shorts did pretty well with Amarin for quite a while now.
Expect covering anytime now and based on this I have been accumulating more and more shares at this very low share price.